Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY - Get Free Report) was the target of a significant decline in short interest in September. As of September 30th, there was short interest totalling 100 shares, a decline of 66.7% from the September 15th total of 300 shares. Based on an average daily volume of 300 shares, the short-interest ratio is currently 0.3 days.
Aspen Pharmacare Trading Down 1.2 %
APNHY traded down $0.13 during trading on Thursday, hitting $10.93. 161 shares of the stock traded hands, compared to its average volume of 542. Aspen Pharmacare has a twelve month low of $8.45 and a twelve month high of $13.69. The company has a quick ratio of 1.07, a current ratio of 1.81 and a debt-to-equity ratio of 0.30. The business has a 50 day moving average price of $11.89 and a 200 day moving average price of $12.14.
Aspen Pharmacare Cuts Dividend
The company also recently disclosed a dividend, which was paid on Tuesday, October 8th. Shareholders of record on Friday, September 20th were given a dividend of $0.1202 per share. The ex-dividend date of this dividend was Friday, September 20th.
Aspen Pharmacare Company Profile
(
Get Free Report)
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
Featured Stories
Before you consider Aspen Pharmacare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Pharmacare wasn't on the list.
While Aspen Pharmacare currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.